Osteopontin (OPN) expression in thyroid carcinoma.

Juliane Briese(Ontario Institute for Cancer Research), L. Sylvia(University Hospitals of Cleveland), Shereen Ezzat(Princess Margaret Cancer Centre), Wei Liu(Second People’s Hospital of Yibin), Sonia Cheng(University Health Network), Ana‐Maria Bamberger, Christoph Wagener, Daniel A. Winer(University of Southern California)

PubMed

May 1, 2010

Cited by 29

Related Papers

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

|JAMA Oncology|2016|1.4k

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

|Nature|2019|982

Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization

|Journal of Neuroinflammation|2020|609

Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations

|Journal of Medicinal Chemistry|2014|587

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

|Nature Genetics|2013|374